Biodesix, Inc.BDSXNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+12.5%
5Y CAGR+20.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+12.5%/yr
vs +24.1%/yr prior
5Y CAGR
+20.2%/yr
Recent deceleration
Acceleration
-11.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
7 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$87.55M+8.8%
2024$80.45M+19.4%
2023$67.39M+9.6%
2022$61.46M+21.7%
2021$50.52M+44.9%
2020$34.86M+13.8%
2019$30.64M+18.3%
2018$25.90M-